ongo
outburst
coronaviru
diseas
rattl
entir
human
popul
potenti
lifethreaten
acut
medic
complic
death
worldwid
distinct
coronaviru
design
sever
acut
respiratori
syndrom
sar
determin
account
ongo
respons
human
propos
origin
bat
pangolin
first
incid
transmiss
anim
human
known
occur
wuhan
hubei
provinc
china
late
sinc
continu
emerg
world
persontoperson
transmiss
viral
droplet
victim
encount
report
develop
wide
rang
clinic
symptom
includ
dri
cough
sore
throat
fever
bodi
pain
headach
abdomin
pain
diarrhoea
fatigu
sever
stage
infect
known
caus
pneumonia
acut
respiratori
failur
encephalopathi
multiorgan
dysfunct
therebi
lead
death
gener
coronavirus
known
cross
bloodbrain
barrier
bbb
affect
central
nervou
system
cn
grow
j
u
r
n
l
p
r
e
p
r
f
patholog
impact
lung
heart
brain
belong
famili
positivestrand
rna
virus
genu
betacoronaviru
share
genet
similar
two
viral
strain
appear
origin
bat
angiotensinconvert
enzym
recogn
receptor
thu
cell
express
vulner
infect
consid
main
target
gene
highli
express
respiratori
tract
thu
lung
major
hotspot
infect
pathogen
event
howev
infect
appear
take
place
also
gastrointestin
tract
cardiovascular
system
brain
organ
known
express
individu
diabet
obes
hypertens
cardiovascular
disord
recognis
highli
suscept
infect
lead
develop
abnorm
express
function
link
diabet
obes
hypertens
cardiovascular
disord
moreov
recent
find
suggest
densiti
cell
increas
upon
age
express
found
higher
men
women
sinc
appear
affect
men
women
mani
countri
infect
develop
variou
symptom
host
acut
respiratori
distress
syndrom
ard
repres
patholog
hallmark
covid
mani
case
pneumonia
appear
major
clinic
consequ
infect
due
promin
proinflammatori
process
alveoli
lung
mani
report
vivo
vitro
studi
histopatholog
find
postmortem
human
j
u
r
n
l
p
r
e
p
r
f
lung
suggest
sarscov
caus
apoptosi
alveolar
cell
degener
small
blood
vessel
lung
intens
condit
respiratori
arrest
major
caus
associ
death
addit
avail
clinic
data
suggest
signific
portion
patient
hypertens
cardiovascular
diseas
medic
use
manag
symptom
hypertens
cardiovascular
disord
associ
diabet
known
induc
express
thu
correl
individu
hypertens
diabet
cardiovascular
disord
high
risk
infect
develop
recent
report
blood
paramet
indic
elev
level
creatin
kinas
lactat
dehydrogenas
signific
proport
individu
elev
level
creatin
kinas
lactat
dehydrogenas
circul
known
biomark
muscl
degener
tissu
damag
variou
organ
includ
heart
liver
moreov
cardiac
arrest
increasingli
notic
one
reason
mortal
associ
covidj
u
r
n
l
p
r
e
p
r
f
sarscov
invad
brain
olfactori
epithelium
induc
neuron
death
transgen
mous
model
express
human
gene
though
human
subject
autoimmun
disord
like
multipl
sclerosi
report
highli
suscept
get
infect
neurolog
abnorm
increasingli
expect
critic
stage
individu
viral
infect
mediat
neuropathogen
brain
region
regul
respiratori
cardiac
gustatori
olfactori
function
might
highli
relev
case
addit
may
exhibit
abnorm
regul
hpa
associ
panic
anxieti
depressionlik
disord
may
need
addit
line
scientif
focu
consid
fact
infect
might
impair
brain
function
level
impair
synapt
plastic
neuroinflamm
neurodegener
abnorm
neurogenesi
gliosi
lead
cognit
impair
dementia
similar
neuroinvas
virus
includ
herp
simplex
viru
polioviru
hiv
moreov
gene
express
function
link
cerebr
blood
flow
cbf
physiolog
state
also
expect
infect
mediat
abnorm
regul
gene
recent
studi
reveal
signific
portion
victim
overlap
sign
cerebrovascular
diseas
taken
bont
harm
biolog
substanc
current
known
human
bont
mainli
produc
strain
anaerob
sporeform
bacterium
clostridium
botulinum
seven
major
serotyp
bont
character
design
type
g
among
bont
type
b
e
f
directli
like
induc
lethal
human
diseas
structur
bont
consist
heavi
light
polypeptid
chain
kda
size
respect
coupl
disulfid
bridg
heavi
chain
bont
bind
receptor
presynapt
termin
cholinerg
neuron
enter
cytoplasm
neuron
receptormedi
endocytosi
disulphid
bond
two
polypeptid
chain
bont
disassoci
gain
activ
form
light
chain
bind
inactiv
protein
like
synaptosomalassoci
protein
snap
vesicleassoci
membran
protein
vamp
syntaxin
respons
fusion
neurotransmitt
contain
vesicl
lipid
bilay
synapt
cleft
therebi
prevent
releas
acetylcholin
ach
cholinerg
parasympathet
postganglion
sympathet
nerv
end
bontsmedi
blockad
ach
releas
subsequ
arrest
cholinerg
signal
synapt
junction
regard
induc
dread
muscl
paralysi
death
bont
known
induc
symptom
like
dryness
mouth
eye
urinari
retent
fluctuat
blood
pressur
abnorm
heart
rate
fatigu
dyspnoea
lung
primari
target
organ
bont
inhal
induc
acut
pneumon
paralysi
breath
muscl
lead
respiratori
arrest
howev
mild
dose
purifi
form
bont
extens
implement
treat
wide
rang
clinic
symptom
notabl
therapeut
bont
implement
reduc
sever
diseas
j
u
r
n
l
p
r
e
p
r
f
provid
cure
clinic
condit
includ
hyperhidrosi
chronic
migrain
strabismu
hemifaci
spasm
blepharospasm
abnorm
heart
rate
dysphagia
urinari
bladder
dysfunct
moreov
mild
therapeut
dose
bont
clearli
shown
provid
benefici
effect
condit
obstruct
lung
function
like
chronic
cough
bronchiti
asthma
dyspnoea
besid
therapeut
bont
implement
attenu
number
neurolog
disord
exhibit
characterist
differ
form
movement
disord
cerebr
palsi
notabl
therapeut
bont
clinic
practis
control
abnorm
movement
disord
notic
dystonia
huntington
diseas
hd
spinocerebellar
ataxia
sca
amyotroph
later
sclerosi
al
parkinson
diseas
pd
spastic
stroke
differ
form
tic
disord
though
caus
factor
clinic
symptom
aforement
disord
highli
dissimilar
therapeut
bont
appear
yield
benefici
effect
regardless
aetiolog
differ
taken
togeth
insight
potenti
molecular
target
therapeut
bont
would
great
help
extend
cur
potenti
combat
refractori
ongo
diseas
human
thu
far
induc
acut
ard
respons
pneumonia
respiratori
arrest
implic
key
determin
factor
extend
casualti
crisi
worldwid
meanwhil
cardiac
arrest
result
associ
heart
failur
also
link
mortal
individu
j
u
r
n
l
p
r
e
p
r
f
covid
besid
appear
enter
brain
elicit
neuropathogen
variou
brain
region
control
bodi
temperatur
repar
heart
beat
studi
neuropatholog
studi
deriv
patient
experiment
anim
strongli
indic
also
induc
neuropatholog
outcom
like
neuroinvas
virus
owe
aforement
fact
li
yc
cowork
recent
report
patient
exhibit
mani
neurolog
sign
indic
brainstem
highli
vulner
subject
moreov
ct
mri
base
find
reveal
thalamu
medial
tempor
lobe
subinsular
region
affect
develop
encephalopathi
appar
evid
brain
subject
consid
fact
expect
individu
recov
high
risk
onset
neurolog
motor
cognit
deficit
psychiatr
symptom
therefor
addit
aim
druggabl
strategi
peripher
system
level
brain
repres
one
major
therapeut
target
manag
symptom
evad
relat
mortal
though
inhibit
express
function
gene
use
inhibitor
may
help
prevent
would
yield
ultim
cure
posit
case
apart
vaccin
base
prevent
unaffect
popul
number
medic
measur
may
consid
order
manag
provid
effectu
defenc
follow
reduct
viral
load
pharmacolog
genet
interferencebas
intervent
therapi
boost
immun
posit
case
follow
assign
antiinflammatori
regim
reduc
mediat
chronic
proinflammatori
respons
supplement
cytoprotect
agent
implement
neurotroph
support
sustain
neuroplast
mani
drug
individu
j
u
r
n
l
p
r
e
p
r
f
meet
one
aforement
strategi
identif
singl
drug
establish
strategi
multipurpos
therapeut
potenti
might
highli
appropri
moment
therapeut
form
bont
approv
food
drug
administr
fda
treatment
mani
clinic
condit
includ
chronic
headach
dystonia
besid
bont
licens
use
antiag
cosmet
particular
mild
therapeut
bont
inject
proven
benefici
headach
bodi
pain
persist
fever
chronic
cough
pneumonia
dyspnoea
consid
gener
clinic
symptom
notabl
signific
portion
patient
report
exhibit
lymphopenia
condit
low
level
lymphocyt
blood
therapeut
bont
inject
appear
elev
immun
cell
count
includ
platelet
count
blood
might
help
fight
enhanc
antigen
present
macrophagesmedi
phagocytosi
elimin
virul
factor
moreov
therapeut
bont
known
avert
irregular
heart
rhythm
even
open
heart
surgeri
therapeut
bont
inject
report
improv
blood
circul
oxygen
suppli
therebi
improv
surviv
rate
subject
ischem
condit
besid
implement
therapeut
bont
emin
clinic
practic
manag
movement
disord
wide
rang
neurolog
deficit
remark
therapeut
bont
appear
provid
neuroprotect
cerebr
ischaem
insult
eventu
exist
list
diseas
treat
therapeut
bont
associ
increas
level
respect
organ
circul
exampl
abnorm
level
function
recogn
j
u
r
n
l
p
r
e
p
r
f
biomark
therapeut
target
chronic
headach
dyspnoea
bronchiti
cardiovascular
disord
hypertens
neuroinflamm
neurolog
disord
underli
mechan
therapeut
bont
recoveri
aforement
clinic
complic
remain
unclear
therapeut
bont
propos
suppress
express
taken
togeth
therapeut
bont
may
also
use
prevent
measur
infect
popul
risk
recent
rigor
implement
mani
drug
therapeut
strategi
envisag
predict
clinic
outcom
propos
drug
therapi
major
focu
underli
mode
action
possibl
advers
effect
associ
therapeut
approach
may
exclud
exampl
hydroxychloroquin
propos
treatment
regim
along
azithromycin
howev
exist
consider
remark
antivir
mechan
action
drug
probabl
effect
reduc
patholog
event
remain
unknown
besid
use
drug
report
associ
fatal
side
effect
transplant
differ
type
stem
cell
propos
improv
outcom
use
stem
cell
known
associ
risk
develop
tumor
growth
metastasi
howev
mount
optim
gener
implement
aforement
drug
cellbas
therapeut
covid
fda
indic
potenti
danger
bont
therapeut
agent
claim
bont
could
spread
beyond
inject
site
notabl
high
dose
bont
known
elicit
advers
effect
cn
toxic
effect
found
due
treatment
use
bont
could
neutral
use
avail
antibodi
bont
besid
implement
antioxid
along
bont
treatment
also
report
minim
side
effect
moreov
clearli
report
advers
effect
therapeut
bont
temporari
revers
use
bont
low
dose
report
compar
safe
repeatedli
demonstr
mild
dose
bont
attenu
mani
human
diseas
even
unit
eventu
mild
dose
bont
inject
accept
practic
aesthet
procedur
even
healthi
individu
despit
rare
report
advers
effect
depend
upon
criteria
recent
retrospect
studi
chiu
sy
indic
fda
approv
unit
bont
maximum
dose
per
treatment
session
implement
patient
neurolog
deficit
interv
even
highend
dose
bont
report
improv
function
outcom
patient
without
obviou
advers
effect
therefor
mild
dose
bont
translat
benefit
individu
present
exponenti
incess
requir
ultim
erad
therapi
plan
like
nationwid
lockdown
social
distanc
selfquarantin
impos
mani
countri
avoid
spread
establish
vaccin
identifi
pharmacolog
strategi
diseas
modifi
therapi
j
u
r
n
l
p
r
e
p
r
f
treatment
like
ivermectin
gain
frontlin
attent
therapeut
efficaci
need
test
ad
therapeut
bont
regard
magic
bullet
appear
proven
cur
effect
mani
explic
symptom
includ
respiratori
failur
cardiac
defect
neurolog
deficit
importantli
therapeut
bont
capac
migrat
intramuscular
inject
site
brain
organ
therapeut
bont
rel
safe
benefici
effect
singl
therapeut
dose
bont
appear
long
last
therapeut
form
bont
avail
brand
name
like
onabotulinumtoxina
dysport
bocoutur
jeuveau
countri
thu
articl
strongli
propos
concept
therapeut
form
bont
also
consid
potent
treatment
howev
high
precaut
measur
author
declar
compet
interest
receptor
differ
popul
cell
discov
http
